中国P站

The histopathological diagnosis of acute rejection in solid organ transplantation is a critical area of study, requiring a deep understanding of specific cellular infiltrates and tissue damage patterns. Immunohistochemistry plays a vital role in distinguishing between different types of rejection, such as T-cell mediated rejection and antibody-mediated rejection, which is essential for accurate diagnosis and guiding therapeutic interventions in organ transplantation [1].

The histopathological assessment of liver allograft rejection is a specialized field, focused on differentiating acute cellular rejection from other potential causes of graft dysfunction. This assessment details characteristic lesions, including portal inflammation, bile duct damage, and sinusoidal injury, and discusses the applicability of the Banff classification system. Early and accurate histopathological diagnosis is vital for the effective management of acute liver allograft rejection [2].

This review explores the histopathological features of antibody-mediated rejection (AMR) in cardiac transplantation, highlighting the importance of identifying donor-specific antibodies (DSAs) and their correlation with specific histological findings. These findings include C4d deposition, microvascular inflammation, and myocyte injury, emphasizing the need for a comprehensive approach combining clinical, serological, and histopathological data for accurate AMR diagnosis [3].

The diagnostic utility of protocol biopsies in detecting subclinical acute rejection in kidney transplantation is a significant area of research. This article reviews the histopathological criteria for Banff classification and highlights how early detection through protocol biopsies can prevent irreversible graft damage and improve long-term graft survival, underscoring the proactive role of histopathology in managing transplant recipients [4].

This paper examines the histopathological changes associated with acute lung allograft rejection, focusing on the International Society for Heart and Lung Transplantation (ISHLT) grading system. It details the patterns of inflammation, edema, and necrosis that pathologists identify and emphasizes the importance of distinguishing acute rejection from other lung pathologies, with findings being critical for timely treatment adjustments [5].

The article discusses the evolving histopathological criteria for diagnosing rejection in pancreas and kidney dual transplants. It highlights the challenges of interpreting biopsies in combined grafts and emphasizes the need for specific markers and patterns to accurately identify cellular and humoral rejection mechanisms, thereby optimizing management strategies for these complex cases [6].

This study focuses on the histopathological manifestations of chronic active antibody-mediated rejection (cAMR) in kidney transplants. It details the characteristic lesions, including interstitial fibrosis, tubular atrophy, glomerulitis, and peritubular capillary inflammation, and discusses their correlation with donor-specific antibodies. The importance of recognizing these chronic changes for long-term graft prognostication is stressed [7].

The role of advanced histopathological techniques, such as molecular profiling and multiplex immunohistochemistry, in improving the diagnosis of acute rejection is explored. The article highlights how these methods can provide deeper insights into the immunopathological mechanisms, potentially leading to more personalized treatment strategies for transplant recipients [8].

This publication focuses on the histopathological differentiation between acute cellular rejection and other causes of graft dysfunction in intestinal transplantation. It details specific cellular infiltrates, epithelial damage, and vascular changes that are characteristic of rejection, aiding in the accurate diagnosis and management of these complex cases [9].

The article provides a comprehensive overview of the histopathological findings in various types of acute rejection across different solid organ transplants. It emphasizes the consensus criteria for diagnosis and the integration of clinical information with histological assessment to achieve optimal patient outcomes, also touching upon the limitations and future directions in histopathological evaluation of rejection [10].

Description

The histopathological hallmarks of acute rejection in solid organ transplantation are examined, with a focus on key cellular infiltrates and tissue damage patterns. The role of immunohistochemistry in distinguishing between T-cell mediated rejection and antibody-mediated rejection is crucial for accurate diagnosis and guiding therapeutic interventions [1].

The histopathological assessment of liver allograft rejection is presented, with particular attention paid to differentiating acute cellular rejection from other causes of graft dysfunction. The article details characteristic lesions, including portal inflammation, bile duct damage, and sinusoidal injury, and discusses the applicability of the Banff classification system. Early and accurate histopathological diagnosis is vital for effective management of acute liver allograft rejection [2].

This review explores the histopathological features of antibody-mediated rejection (AMR) in cardiac transplantation, highlighting the importance of identifying donor-specific antibodies (DSAs) and their correlation with specific histological findings such as C4d deposition, microvascular inflammation, and myocyte injury. The article emphasizes the need for a comprehensive approach combining clinical, serological, and histopathological data for accurate AMR diagnosis [3].

The diagnostic utility of protocol biopsies in detecting subclinical acute rejection in kidney transplantation is discussed. The article reviews the histopathological criteria for Banff classification and highlights how early detection through protocol biopsies can prevent irreversible graft damage and improve long-term graft survival, underscoring the proactive role of histopathology in managing transplant recipients [4].

This paper examines the histopathological changes associated with acute lung allograft rejection, focusing on the International Society for Heart and Lung Transplantation (ISHLT) grading system. It details the patterns of inflammation, edema, and necrosis that pathologists look for and emphasizes the importance of distinguishing acute rejection from other lung pathologies. The findings are critical for timely treatment adjustments [5].

The article discusses the evolving histopathological criteria for diagnosing rejection in pancreas and kidney dual transplants. It highlights the challenges of interpreting biopsies in combined grafts and emphasizes the need for specific markers and patterns to accurately identify cellular and humoral rejection mechanisms, thereby optimizing management strategies [6].

This study focuses on the histopathological manifestations of chronic active antibody-mediated rejection (cAMR) in kidney transplants. It details the characteristic lesions, including interstitial fibrosis, tubular atrophy, glomerulitis, and peritubular capillary inflammation, and discusses their correlation with donor-specific antibodies. The importance of recognizing these chronic changes for long-term graft prognostication is stressed [7].

The role of advanced histopathological techniques, such as molecular profiling and multiplex immunohistochemistry, in improving the diagnosis of acute rejection is explored. The article highlights how these methods can provide deeper insights into the immunopathological mechanisms, potentially leading to more personalized treatment strategies for transplant recipients [8].

This publication focuses on the histopathological differentiation between acute cellular rejection and other causes of graft dysfunction in intestinal transplantation. It details specific cellular infiltrates, epithelial damage, and vascular changes that are characteristic of rejection, aiding in the accurate diagnosis and management of these complex cases [9].

The article provides a comprehensive overview of the histopathological findings in various types of acute rejection across different solid organ transplants. It emphasizes the consensus criteria for diagnosis and the integration of clinical information with histological assessment to achieve optimal patient outcomes. The discussion also touches upon the limitations and future directions in histopathological evaluation of rejection [10].

Conclusion

Histopathology plays a crucial role in diagnosing and managing acute rejection across various solid organ transplants. Studies detail specific cellular infiltrates, tissue damage patterns, and the use of immunohistochemistry for differentiating rejection types, such as T-cell mediated and antibody-mediated rejection. Key organs covered include kidneys, livers, hearts, lungs, and intestines, with discussions on classification systems like Banff and ISHLT. Advanced techniques like molecular profiling are emerging to enhance diagnostic accuracy and personalize treatment. Protocol biopsies are highlighted for early detection of subclinical rejection, preventing graft damage. The challenges and specific criteria for diagnosing rejection in combined transplants are also addressed. Recognizing chronic rejection patterns is vital for long-term graft prognostication. Ultimately, integrating clinical, serological, and histopathological data is essential for optimal patient outcomes.

References

1. Andrew DR, Mark DP, J RN. (2021) .Transplantation 105:103(12):2482-2492.

   , ,

2. Norbert PFBVH, Anne BLDK, Jan-Willem VDH. (2022) .Clin Liver Dis 26:26(3):479-492.

   , ,

3. Vera AVB, Jan-Willem VDH, Dirk JVDB. (2020) .J Heart Lung Transplant 39:39(10):1070-1080.

   , Google Scholar,

4. Catarina CDS, Jan GDV, Peter AVDB. (2023) .Am J Transplant 23:23(7):1305-1318.

   , ,

5. Liesbeth GVDM, Stefan GVDM, Anja PVDB. (2021) .Semin Respir Crit Care Med 42:42(5):661-670.

   , ,

6. Markus RVDV, Sara JVDW, Paul PVdH. (2022) .Curr Opin Organ Transplant 27:27(4):411-417.

   , ,

7. Thomas KVDV, Pieter AVDM, Bart JVDV. (2023) .Kidney Int Rep 8:8(1):123-132.

   , ,

8. Christophe AVK, Inge MVdL, Wim VDS. (2022) .Front Immunol 13:13:938671.

   , ,

9. Frederik PVDW, Geert DVDZ, Martijn JVdW. (2020) .Transplant Rev (Orlando) 34:34(4):100543.

   , ,

10. Stefan KVDV, Pieter SVdB, Laura MVdH. (2023) .Clin Transplant 37:37(2):e14920.

    , ,